EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$77.17
-1.70% today
Updated 2026-06-05
Market cap
$49.01B
P/E ratio
46.01
P/S ratio
7.77x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $89
Volume
5.3M
Edwards Lifesciences Corp (EW) Insider transactions
Net insider activity
Net buying (393,589 shares)
Buy transactions
43
Sell transactions
57
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | DAHL, ANDREW M. | SVP, Corporate Controller | Sale | 568 | $86.08 | $48893.44 |
| 2026-05-27 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 23,145 | $86.42 | $2.00M |
| 2026-05-22 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Sale | 1,500 | $84.60 | $126905.25 |
| 2026-05-18 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 620 | — | — |
| 2026-05-18 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 620 | $81.14 | $50306.80 |
| 2026-05-15 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 9,968 | $82.07 | $818105.66 |
| 2026-05-15 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 8,000 | $81.82 | $654572.80 |
| 2026-05-12 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 35,506 | $77.92 | $2.77M |
| 2026-05-12 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 26,640 | — | — |
| 2026-05-12 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 845 | $78.40 | $66250.28 |
| 2026-05-11 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 47,207 | — | — |
| 2026-05-11 | ZOVIGHIAN, BERNARD J | Director, CEO | Buy | 47,207 | — | — |
| 2026-05-11 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 26,198 | $79.96 | $2.09M |
| 2026-05-11 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 5,489 | — | — |
| 2026-05-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 19,830 | — | — |
| 2026-05-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Buy | 19,830 | — | — |
| 2026-05-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 11,004 | $79.96 | $879879.84 |
| 2026-05-11 | MARKOWITZ, WAYNE | CVP, JAPAC | Sale | 593 | $79.73 | $47279.89 |
| 2026-05-11 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 362 | $79.96 | $28945.52 |
| 2026-05-11 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Sale | 13,583 | — | — |
| 2026-05-11 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Buy | 13,583 | — | — |
| 2026-05-11 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Sale | 7,538 | $79.96 | $602738.48 |
| 2026-05-11 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 13,457 | — | — |
| 2026-05-11 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Buy | 13,457 | — | — |
| 2026-05-11 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 7,469 | $79.96 | $597221.24 |
| 2026-05-08 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 5,398 | $82.76 | $446738.48 |
| 2026-05-08 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 4,222 | — | — |
| 2026-05-08 | VALERIANI, NICHOLAS J | Director | Buy | 5,127 | — | — |
| 2026-05-08 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 1,661 | $82.76 | $137464.36 |
| 2026-05-08 | STONE, HEISZ LESLIE | Director | Buy | 3,251 | — | — |
| 2026-05-08 | SEQUEIRA, RAMONA | Director | Buy | 3,251 | — | — |
| 2026-05-08 | MARKOWITZ, WAYNE | CVP, JAPAC | Sale | 226 | $82.76 | $18703.76 |
| 2026-05-08 | LORANGER, STEVEN R | Director | Buy | 3,251 | — | — |
| 2026-05-08 | LORANGER, STEVEN R | Director | Buy | 1,064 | — | — |
| 2026-05-08 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 450 | $82.76 | $37242.00 |
| 2026-05-08 | LAVIOLETTE, PAUL A | Director | Buy | 3,251 | — | — |
| 2026-05-08 | GALLAHUE, KIERAN | Director | Buy | 3,251 | — | — |
| 2026-05-08 | GALLAHUE, KIERAN | Director | Buy | 1,064 | — | — |
| 2026-05-08 | FEINBERG, DAVID T | Director | Buy | 3,251 | — | — |
| 2026-05-08 | DAVIS, LESLIE C. | Director | Buy | 3,251 | — | — |
| 2026-05-08 | DAHL, ANDREW M. | SVP, Corporate Controller | Sale | 289 | $82.76 | $23917.64 |
| 2026-05-08 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Sale | 1,141 | $82.76 | $94429.16 |
| 2026-05-08 | BRULS, ANNETTE | CVP, EMEACLA | Sale | 84 | $82.76 | $6951.84 |
| 2026-05-08 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 1,038 | $82.76 | $85904.88 |
| 2026-05-07 | ZOVIGHIAN, BERNARD J | Director, CEO | Buy | 43,800 | — | — |
| 2026-05-07 | ZOVIGHIAN, BERNARD J | Director, CEO | Buy | 245,300 | — | — |
| 2026-05-07 | ZOVIGHIAN, BERNARD J | Director, CEO | Buy | 43,800 | — | — |
| 2026-05-07 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 4,153 | $83.20 | $345529.60 |
| 2026-05-07 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 1,373 | $83.20 | $114233.60 |
| 2026-05-07 | MARKOWITZ, WAYNE | CVP, JAPAC | Buy | 5,200 | — | — |
| 2026-05-07 | MARKOWITZ, WAYNE | CVP, JAPAC | Buy | 26,400 | — | — |
| 2026-05-07 | MARKOWITZ, WAYNE | CVP, JAPAC | Buy | 5,200 | — | — |
| 2026-05-07 | MARKOWITZ, WAYNE | CVP, JAPAC | Sale | 264 | $83.20 | $21964.80 |
| 2026-05-07 | LIPPIS, DANIEL J. | CVP, TAVR | Buy | 7,850 | — | — |
| 2026-05-07 | LIPPIS, DANIEL J. | CVP, TAVR | Buy | 39,900 | — | — |
| 2026-05-07 | LIPPIS, DANIEL J. | CVP, TAVR | Buy | 7,850 | — | — |
| 2026-05-07 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 309 | $83.20 | $25708.80 |
| 2026-05-07 | DAHL, ANDREW M. | SVP, Corporate Controller | Buy | 6,745 | — | — |
| 2026-05-07 | DAHL, ANDREW M. | SVP, Corporate Controller | Buy | 3,985 | — | — |
| 2026-05-07 | DAHL, ANDREW M. | SVP, Corporate Controller | Buy | 3,020 | — | — |
| 2026-05-07 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Buy | 9,675 | — | — |
| 2026-05-07 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Buy | 49,100 | — | — |
| 2026-05-07 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Buy | 9,675 | — | — |
| 2026-05-07 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Sale | 674 | $83.20 | $56076.80 |
| 2026-05-07 | BRULS, ANNETTE | CVP, EMEACLA | Buy | 6,650 | — | — |
| 2026-05-07 | BRULS, ANNETTE | CVP, EMEACLA | Buy | 33,700 | — | — |
| 2026-05-07 | BRULS, ANNETTE | CVP, EMEACLA | Buy | 6,650 | — | — |
| 2026-05-07 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Buy | 7,850 | — | — |
| 2026-05-07 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Buy | 44,000 | — | — |
| 2026-05-07 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Buy | 7,850 | — | — |
| 2026-05-07 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 831 | $83.20 | $69139.20 |
| 2026-05-05 | ZOVIGHIAN, BERNARD J | Director, CEO | Buy | 523 | — | — |
| 2026-05-05 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 13,000 | — | — |
| 2026-05-05 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Buy | 13,000 | $59.26 | $770337.10 |
| 2026-05-05 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 11,131 | $82.91 | $922871.21 |
| 2026-05-04 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 1,019 | — | — |
| 2026-05-04 | LIPPIS, DANIEL J. | CVP, TAVR | Buy | 1,019 | $59.26 | $60382.58 |
| 2026-05-03 | ZOVIGHIAN, BERNARD J | Director, CEO | Sale | 515 | $83.98 | $43249.70 |
| 2026-05-03 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 620 | $83.98 | $52067.60 |
| 2026-05-03 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 252 | $83.98 | $21162.96 |
| 2026-05-03 | CHOPRA, DAVEEN | CVP, TMTT & Surgical | Sale | 282 | $83.98 | $23682.36 |
| 2026-05-03 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 469 | $83.98 | $39386.62 |
| 2026-05-01 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 1,019 | — | — |
| 2026-05-01 | LIPPIS, DANIEL J. | CVP, TAVR | Buy | 1,019 | $59.26 | $60382.58 |
| 2026-05-01 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 1,000 | $82.99 | $82988.90 |
| 2026-05-01 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 19 | $83.99 | $1595.77 |
| 2026-04-09 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 13,000 | — | — |
| 2026-04-09 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Buy | 13,000 | $59.26 | $770337.10 |
| 2026-04-09 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 8,324 | $79.79 | $664143.66 |
| 2026-04-09 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 4,676 | $80.50 | $376400.70 |
| 2026-04-06 | LIPPIS, DANIEL J. | CVP, TAVR | Sale | 1,019 | — | — |
| 2026-04-06 | LIPPIS, DANIEL J. | CVP, TAVR | Buy | 1,019 | $59.26 | $60382.58 |
| 2026-04-02 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 22,680 | — | — |
| 2026-04-02 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Buy | 22,680 | $59.26 | $1.34M |
| 2026-04-02 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 18,004 | $80.05 | $1.44M |
| 2026-04-02 | BOBO, DONALD E JR | CVP,Strategy/Corp Development | Sale | 4,676 | $80.59 | $376845.85 |
| 2026-03-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 13,000 | — | — |
| 2026-03-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Buy | 13,000 | $59.26 | $770337.10 |
| 2026-03-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 7,901 | $85.21 | $673227.62 |
| 2026-03-11 | ULLEM, SCOTT B. | CVP, Chief Financial Officer | Sale | 5,099 | $84.46 | $430668.17 |
Frequently asked questions
Are EW insiders buying or selling?
Over the transactions on record, EW insiders have been net sellers, with about $17.42M in stock sold across 57 sales, against 7 open-market purchases.
Does insider selling at EW mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which EW insiders are selling the most?
Recent selling is concentrated in a few names. BOBO, DONALD E JR accounts for the largest share on record, with about $6.08M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.